Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-010136
Filing Date
2017-02-21
Accepted
2017-02-21 16:03:37
Documents
64
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q v459672_10q.htm 10-Q 525843
2 EXHIBIT 31.1 v459672_ex31-1.htm EX-31.1 9983
3 EXHIBIT 31.2 v459672_ex31-2.htm EX-31.2 10565
4 EXHIBIT 32.1 v459672_ex32-1.htm EX-32.1 5015
5 EXHIBIT 32.2 v459672_ex32-2.htm EX-32.2 5146
  Complete submission text file 0001144204-17-010136.txt   4802846

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20161231.xml EX-101.INS 1169592
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20161231.xsd EX-101.SCH 40104
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20161231_cal.xml EX-101.CAL 34039
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20161231_def.xml EX-101.DEF 290058
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20161231_lab.xml EX-101.LAB 298114
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20161231_pre.xml EX-101.PRE 321756
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 17625040
SIC: 2834 Pharmaceutical Preparations